Antikoagülan İlaç Kullanan Hastalarda Nöroaksiyel, Periferal ve Derin Sinir Blokları İçin Güvenli Aralık

Macfarlane AJ, Prasad GA, Chan VW, Brull R. Does regional anesthesia improve outcome after total knee arthroplasty? Clin Orthop Relat Res 2009; 467: 2379-2402.
Horlocker Tt, Vandermeuelen E, Kopp Sl, et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med. 2018 Apr;43(3):263-309. doi: 10.1097/AAP.0000000000000763.
Sibylle Kietaibl, Raquel Ferrandis, Anne Godier, Juan Llau, Clara Lobo, Alan Jr Macfarlane, Christoph J Schlimp, Erik Vandermeulen, Thomas Volk, Christian von Heymann, Morné Wolmarans, Arash Afshari. Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines. Eur J Anaesthesiol. 2022 Feb1;39(2):100-132. doi: 10.1097/EJA.0000000000001600.
Vandermeulen E. Regional anaesthesia and anticoagulation. Best Pract Res Clin Anaesthesiol. 2010; 24:121-31.
Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995; 80:303-9.
Stafford-Smith M. Impaired haemostasis and regional anaesthesia. Can J Anaesth. 1996; 43: R129-41.
Horlocker TT, Wedel DJ. Anticoagulation and neuraxial block: historical perspective, anesthetic implications, and risk management. Reg Anesth Pain Med. 1998; 23:129-34.
Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004; 101:950-9.
Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994;79: 1165-77.
Green L, Machin SJ. Managing anticoagulated patients during neuraxial anaesthesia. Br J Haematol. 2010; 149:195-208.
Hirsh J, Bauer KA, Donati MB, et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133, 141S-59S.
Hirsh J, Raschke R, Warkentin TE, et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108, 258S-75S.
Ruff RL, Dougherty JH Jr. Complications of lumbar puncture followed by anticoagulation. Stroke. 1981; 12:879-81.
Davignon KR, Maslow A, Chaudrey A, et al. CASE 5-2008: Epidural Hematoma: when is it safe to heparinize after the removal of an epidural catheter? J Cardiothorac Vasc Anesth. 2008; 22:774-8.
Rosen Da, Hawkinberry Dw, Rosen Kr, et al. An epidural hematoma in an adolescent patient after cardiac surgery. Anesth Analg. 2004; 98:966-9, table of contents.
Liu SS, Mulroy MF. Neuraxial anesthesia and analgesia in the presence of standard heparin. Reg Anesth Pain Med. 1998; 23:157-63.
Fonseca NM, Pontes JPJ, Perez MV, et al. SBA 2020: Regional anesthesia guideline for using anticoagulants update. Braz J Anesthesiol. Jul-Aug 2020;70(4):364-387. doi: 10.1016/j.bjan.2020.02.006.
Working P. Association of Anaesthetists of Great B, Ireland, Obstetric Anaesthetists A, Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain & Ireland The Obstetric Anaesthetists’ Association Regional Anaesthesia UK. Anaesthesia. 2013; 68:966-72.
Sanderink GJ, Guimart CG, Ozoux ML, et al. Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment. Thromb Res. 2002; 105:225-31.
Weitz JI, Eikelboom JW, Samama MM. New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141, e120S-e51S.
Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecularweight heparin or unfractionated heparin. N Engl J Med. 1995; 332:1330-5.
Douketis JD, Kinnon K, Crowther MA. Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery. Thromb Haemost. 2002; 88:37-40.
Xi M, Beguin S, Hemker HC. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost. 1989; 62:788-91.
Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133, 160S-98S.
Enneking FK, Benzon H. Oral anticoagulants and regional anesthesia: a perspective. Reg Anesth Pain Med. 1998; 23:140-5.
Buvanendran A, Lubenow T, Majewski M, et al. The INR values at removal of epidural catheter in 4013 patients receiving warfarin. Anesthesiology. 2008; 109: A427.
Parvizi J, Viscusi ER, Frank HG, et al. Can epidural anesthesia and warfarin be coadministered? Clin Orthop Relat Res. 2007; 456:133-7.
Liu SS, Buvanendran A, Viscusi ER, et al. Uncomplicated removal of epidural catheters in 4365 patients with international normalized ratio greater than 1.4 during initiation of warfarin therapy. Reg Anesth Pain Med. 2011; 36:231-5.
Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141, e326S-e50S.
Gogarten W, Vandermeulen E, Van Aken H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010; 27:999-1015.
Eikelboom JW, Weitz JI. New anticoagulants. Circulation. 2010;121(13):1523-32. 98.
Garcia D, Libby E, Crowther MA. The new oral anticoagulants. Blood. 2010115:15-20.
Chan NC, Bhagirath V, Eikelboom JW. Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism. Vasc Health Risk Manag. 201511:343-51.
Chan NC, Hirsh J, Ginsberg JS, et al. Betrixaban (PRT054021): pharmacology, dose selection and clinical studies. Future Cardiol. 2014; 10:43-52.
Horlocker Tt. Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy. Br J Anaesth. 2011; 107: i96-106.
Stangier J, Clemens A. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb Hemost. 2009; 15:9S-16S.
Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for Dabigatran Reversal. N Engl J Med. 2015; 373:511-20.
Pollack CV Jr, Reilly PA, Weitz JI. Dabigatran Reversal with Idarucizumab. N Engl J Med. 2017; 377:1691-2.
Kaplan KL. Direct thrombin inhibitors. Expert Opin Pharmacother. 2003; 4:653-66.
Kathiresan S, Shiomura J, Jang IK. Argatroban. J Thromb Thrombolysis. 2002; 13:41-7.
Greinacher A. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy. Expert Rev Cardiovasc Ther. 2004; 2:339-57.
Fonseca NM, Alves RR, Pontes JPJ. Sociedade Brasileira de Anestesiologia. SBA recommendations for regional anesthesia safety in patients taking anticoagulants. Rev Bras Anestesiol. 2014; 64:1-15.
Narouze S, Benzon HT, Provenzano D, et al. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition): Guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2018; 43:225-62.
Capodanno D, Ferreiro JL, Angiolillo DJ. Antiplatelet therapy: new pharmacological agents and changing paradigms. J Thromb Haemost. 2013; 11:316-29.
De Luca G. Glycoprotein IIb-IIIa inhibitors. Cardiovasc Ther. 2012; 30: e242-54.
Oprea AD, Popescu WM. Perioperative management of antiplatelet therapy. Br J Anaesth. 2013; 111:13-7.
Gurbel PA, Bliden KP, Butler K, et al. Randomized doubleblind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation. 2009; 120:2577-85.
Akers WS, Oh JJ, Oestreich JH, et al. Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist. J Clin Pharmacol. 201050:27-35.
Sible AM, Nawarskas JJ. Cangrelor: A New Route for P2Y12 Inhibition. Cardiol Rev. 201725:133-9.
Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008; 359:1238-51.
Kaneda T, Urimoto G, Suzuki T. Spinal epidural hematoma following epidural catheter removal during antiplatelet therapy with cilostazol. J Anesth. 2008; 22:290-3.
Cronberg S, Wallmark E, Soderberg I. Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol. 1984; 33:155-9.
Leese PT, Hubbard RC, Karim A, et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol. 2000; 40:124-32.
Marhofer P, Willschke H, Kettner S. Current concepts and future trends in ultrasound-guided regional anesthesia. Curr Opin Anaesthesiol. 2010; 23:632-6.
Abrahams MS, Aziz MF, Fu RF, et al. Ultrasound guidance compared with electrical neurostimulation for peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials. Br J Anaesth. 2009; 102:408-17.
Martins LE, Ferraro LH, Takeda A, et al. Ultrasound-guided peripheral nerve blocks in anticoagulated patients -case series. Rev Bras Anestesiol. 2017; 67:100-6.